JPM vs PFE: Which Is the Better Buy?
Side-by-side comparison of JPMorgan Chase & Co. and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-05.
JPMorgan Chase & Co. · Financial Services
$316.99
+45.0% upside to fair value
Grade C
High Quality
VS
Pfizer Inc. · Healthcare
$26.33
+28.6% upside to fair value
Grade B
QuantHub Verdict
JPM has more upside to fair value
(+45.0%).
JPM trades at a lower forward P/E
(15.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JPM |
PFE |
| Current Price |
$316.99 |
$26.33 |
| Fair Value Estimate |
$459.64 |
$33.85 |
| Upside to Fair Value |
+45.0%
|
+28.6%
|
| Market Cap |
$854.9B |
$149.8B |
| Forward P/E |
15.0x
|
19.3x
|
| EV / EBITDA |
21.8x
|
12.9x
|
| Price / Sales |
3.0x
|
2.4x
|
| Price / FCF |
8.5x
|
16.5x
|
| Revenue Growth YoY |
+6.9%
|
-1.2%
|
| Gross Margin |
60.9%
|
70.3%
|
| Operating Margin |
26.2%
|
24.7%
|
| Return on Equity |
16.3%
|
8.7%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
11.79%
|
6.06%
|
| Analyst Consensus |
Buy
|
Hold
|
Investment Thesis
JPMorgan Chase & Co. is a leading diversified financial services firm with a strong competitive moat driven by its scale, diversified revenue streams, and long-tenured leadership. The company operates across four main segments: Commercial & Investment Bank, Consumer & Community Banking, Asset & Wealth Management, and Corporate, generating $279.75 billion in revenue in fiscal 2025. Its durable com…
Pfizer Inc. is a leading global pharmaceutical company specializing in drug manufacturing with a strong presence in vaccines, oncology, and primary care. The company benefits from a seasoned leadership team under CEO Albert Bourla, who has driven a strategic transformation focusing on science-driven innovation and portfolio optimization. Despite a high gross margin of 70.3% and solid operating ma…
Accumulation Zones
| Metric |
JPM |
PFE |
| Zone Low |
$344.73 |
$25.39 |
| Zone High |
$390.69 |
$28.77 |
| In Buy Zone? |
Yes
|
Yes
|